发明名称 CARBOXYLIC ACID COMPOUNDS
摘要 <p>A carboxylic acid compound represented by the following general formula (I), its pharmaceutically acceptable salt, a process for producing the same and a drug containing the same as the active ingredient: (I) wherein R&lt;1&gt; represents H or alkyl; m is 2 or 3; n is an integer of from 0 to 2; R&lt;2&gt; represents phenyl, naphthyl, benzofuran or benzothiophene; Q represents -CH2-O-Cyc1, -CH2-Cyc2 or -L-Cyc3; and R&lt;3a&gt; and R&lt;3b&gt; independently represent each hydrogen or alkyl, or R&lt;3a&gt; and R&lt;3b&gt; represent together tetrahydro-2H-pyrane. Because of having antagonism specifically to PGE2 receptors (in particular, EP3 receptor which is one of the subtypes thereof), compounds represented by the general formula (I) are useful in preventing and/or treating itching, pain, urinary disorder or stress-induced diseases.</p>
申请公布号 WO2004069788(A1) 申请公布日期 2004.08.19
申请号 WO2004JP01262 申请日期 2004.02.06
申请人 ONO PHARMACEUTICAL CO;ASADA MASAKI;KOBAYASHI KAORU;NARITA MASAMI;SATO KAZUTOYO;KINOSHITA ATSUSHI;NAGASE TOSHIHIKO;YOSHIKAWA KEN 发明人 ASADA MASAKI;KOBAYASHI KAORU;NARITA MASAMI;SATO KAZUTOYO;KINOSHITA ATSUSHI;NAGASE TOSHIHIKO;YOSHIKAWA KEN
分类号 A61P13/10;A61P17/02;A61P29/00;A61P43/00;C07C235/42;C07D209/18;C07D209/30;C07D213/55;C07D213/65;C07D309/14;C07D317/64;C07D317/66;C07D405/12;C07D407/04;C07D409/04;(IPC1-7):C07C235/42;C07C235/46;C07C237/30;C07C255/54;C07C255/58;C07C323/20;A61K31/192;A61K31/443;A61K31/44;A61K31/404;A61K31/381;A61K31/351 主分类号 A61P13/10
代理机构 代理人
主权项
地址